Affinity Biosensors

Antimicrobial Resistance Diagnostic Challenge Semifinalist

Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test Challenge – CCC Innovation Center 

Affinity Biosensors Ultra-Rapid Phenotypical AST by Microbe Mass Measurement has been selected as a Step 1 semifinalist in the Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test Challenge by the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) of the Office of the Assistant Secretary for Preparedness and Response (ASPR). The federal prize competition will award up to a total of $20 million in prizes, subject to the availability of funds, for innovative rapid, point-of-need diagnostic tests to combat the emergence and spread of drug resistant bacteria.

Comments are closed.

About Affinity Biosensors

Contact Details

  • Address: Suite 101, 222 East Canon Perdido St., Santa Barbara CA

  • Phone: +1 (805) 960-5100

  • Email:

Dave's Blog

Popular App Notes

View More